2 ratings / 5 average

Asymptomatic Microscopic Hematuria: 
Clinical Significance and Evaluation

Abdulaziz M Althunayan, MD, and Wassim Kassouf, MD, FRCS(C)

Asymptomatic microscopic hematuria (AMH) is a common finding, particularly among men aged 50–60 years and postmenopausal women, and has a prevalence rate ranging from 1% to 21% [1–5]. This difference in the published prevalence rates is influenced by variations in the age, sample size, sex ratio of the population screened, method of hematuria identification, as well as duration of follow-up and the number of screening studies per patient [1–5].

Return to top


Long-Term Effects of Testicular Cancer Treatment
Jayakrishnan Jayachandran, MD, Stephen J Freedland, MD1,2,3, and Judd W Moul, MD1.
CML Urology
The Utility of Bisphosphonates in Kidney Cancer: Safety and Tolerability
Liam Welsh MBBS, MRCP, PhD1, and Vincent Khoo MBBS, FRACR, FRCR, MD1,2
CML Urology
Exosomes in Neurological Disease
Andrew F Hill
CML Neurology
Phosphodiesterase-5 inhibitors for the treatment of benign prostatic hyperplasia-related lower urinary tract symptoms
Konstantinos Giannitsas, MD, PhD, and Petros Perimenis, MD, PhD

CML Urology
Surgical Management of Pediatric Urolithiasis
Kemal Sarica, MD, and Faruk Yencilek, MD

CML Urology